Maxis Clinical Sciences launches Real-World Evidence Solutions service

Maxis Clinical Sciences launches Real-World Evidence Solutions offering diverse real-world data capture and analysis to enhance clinical research and care.

Maxis Clinical Sciences, a clinical research consultancy for small to medium-sized pharmaceuticals and life sciences companies worldwide, has announced the release of its new Real-World Evidence (RWE) Solutions service. By enabling the capture and integration of real-world data (RWD) from diverse patient populations and source types into analysis, the company aims to enhance both clinical research and patient care.

A stated goal of Maxis Clinical Sciences is to bridge the gap between clinical research and digital innovation, with a focus on patient-centric solutions.

“Real-world evidence is set to optimize evidence-based medicine. By capturing data from diverse patient populations in real-world settings, we can create a thorough and accurate pool of evidence,” said Kavita Lamror, Partner for RWE and Digital Transformation at Maxis Clinical Sciences. “Our RWE Solutions simplify the integration of this evidence into clinical trials, aiding companies in their drug discovery and development efforts.”

Maxis Clinical Sciences’ RWE Solutions has been developed to integrate diverse RWD sources. These include patient-reported outcomes and data from wearable devices, developed to enhance patient engagement and data quality.

The RWE Solutions feature an integrated technology and service platform that accelerates the collection and analysis of real-world data. The suite includes pre-configured modules for patient recruitment, eligibility screening, enrollment, data capture, and participant engagement. The system will enable sponsors to gain invaluable insights into drug efficacy in real-world scenarios, while also expanding access to global patient populations.

The RWE insights gained can be applied to further: personalized medicine; regulatory submissions; health economics and outcomes research; drug repurposing; and patient recruitment.

---

You may also be interested in:

• WEBINAR: SURF screening tool to determine suitability of using real-world evidence
• Challenges and opportunities in using real-world evidence to support the approval of companion diagnostics in the era of precision medicine: an interview with Brian Clancy, Foundation Medicine
• Case studies of FDA recently approved product applications using real-world evidence: an interview with Jie Li, Gerald Dal Pan and John Concato, FDA